2021 Form 10-K Financial Statement

#000147793222002081 Filed on April 06, 2022

View on sec.gov

Income Statement

Concept 2021 2020 Q4 2020
Revenue $34.07K $67.91K
YoY Change -49.83%
Cost Of Revenue $21.70K $51.83K
YoY Change -58.14%
Gross Profit $12.37K $16.07K
YoY Change -23.02%
Gross Profit Margin 36.32% 23.67%
Selling, General & Admin $331.5K $330.4K
YoY Change 0.32%
% of Gross Profit 2679.09% 2055.76%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $313.6K $243.8K
YoY Change 28.64%
Operating Profit -$301.3K -$227.7K
YoY Change 32.28%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$301.3K -$227.7K
YoY Change 32.28%
Income Tax $0.00 $0.00
% Of Pretax Income
Net Earnings -$316.0K -$227.7K
YoY Change 38.74%
Net Earnings / Revenue -927.42% -335.36%
Basic Earnings Per Share
Diluted Earnings Per Share -$0.01 -$0.01
COMMON SHARES
Basic Shares Outstanding
Diluted Shares Outstanding

Balance Sheet

Concept 2021 2020 Q4 2020
SHORT-TERM ASSETS
Cash & Short-Term Investments $9.540K $0.00
YoY Change
Cash & Equivalents $0.00
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory $31.45K $50.27K $50.27K
Prepaid Expenses
Receivables $0.00 $82.00 $80.00
Other Receivables $0.00 $0.00
Total Short-Term Assets $40.99K $50.35K
YoY Change -18.59%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $0.00 $0.00
YoY Change
TOTAL ASSETS
Total Short-Term Assets $40.99K $50.35K
Total Long-Term Assets $0.00 $0.00
Total Assets $40.99K $50.35K $50.35K
YoY Change -18.59%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $222.1K $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $222.1K $0.00 $0.00
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt $36.42K $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $36.42K $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $222.1K $0.00 $0.00
Total Long-Term Liabilities $36.42K $0.00
Total Liabilities $258.5K $0.00 $0.00
YoY Change
SHAREHOLDERS EQUITY
Retained Earnings $0.00
YoY Change
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$217.5K $50.35K $50.35K
YoY Change
Total Liabilities & Shareholders Equity $40.99K $50.35K $50.35K
YoY Change -18.59%

Cashflow Statement

Concept 2021 2020 Q4 2020
OPERATING ACTIVITIES
Net Income -$316.0K -$227.7K
YoY Change 38.74%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$260.5K -$95.29K
YoY Change 173.39%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00
YoY Change
Cash From Investing Activities $0.00 $0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $75.00K $0.00
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $270.1K $95.29K
YoY Change 183.4%
NET CHANGE
Cash From Operating Activities -$260.5K -$95.29K
Cash From Investing Activities $0.00 $0.00
Cash From Financing Activities $270.1K $95.29K
Net Change In Cash $9.543K $0.00
YoY Change
FREE CASH FLOW
Cash From Operating Activities -$260.5K -$95.29K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021 dei Auditor Location
AuditorLocation
Dallas, Texas
CY2021Q4 us-gaap Cash
Cash
9543 USD
CY2020Q4 us-gaap Cash
Cash
0 USD
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
0 USD
CY2020Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
82 USD
CY2021Q4 us-gaap Inventory Net
InventoryNet
31449 USD
CY2020Q4 us-gaap Inventory Net
InventoryNet
50265 USD
CY2021Q4 us-gaap Assets
Assets
40992 USD
CY2020Q4 us-gaap Assets
Assets
50347 USD
CY2021Q4 us-gaap Notes Payable Related Parties Classified Current
NotesPayableRelatedPartiesClassifiedCurrent
195050 USD
CY2020Q4 us-gaap Notes Payable Related Parties Classified Current
NotesPayableRelatedPartiesClassifiedCurrent
0 USD
CY2021Q4 crp Long Term Note Payable To Related Party Current Portion
LongTermNotePayableToRelatedPartyCurrentPortion
27034 USD
CY2020Q4 crp Long Term Note Payable To Related Party Current Portion
LongTermNotePayableToRelatedPartyCurrentPortion
0 USD
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
222084 USD
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
0 USD
CY2021Q4 us-gaap Notes Payable Related Parties Noncurrent
NotesPayableRelatedPartiesNoncurrent
36422 USD
CY2020Q4 us-gaap Notes Payable Related Parties Noncurrent
NotesPayableRelatedPartiesNoncurrent
0 USD
CY2021Q4 us-gaap Liabilities
Liabilities
258506 USD
CY2020Q4 us-gaap Liabilities
Liabilities
0 USD
CY2021Q4 us-gaap Investments
Investments
0 USD
CY2020Q4 us-gaap Investments
Investments
50347 USD
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
5000000000 shares
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
37103394 shares
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
0 shares
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
3710 USD
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
74374 USD
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-301261 USD
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
0 USD
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-217514 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
50347 USD
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
40992 USD
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
50347 USD
CY2021 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
21696 USD
CY2021 us-gaap Gross Profit
GrossProfit
12373 USD
CY2020 us-gaap Gross Profit
GrossProfit
16073 USD
CY2021 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
313634 USD
CY2020 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
243815 USD
CY2021 us-gaap Operating Expenses
OperatingExpenses
313634 USD
CY2020 us-gaap Operating Expenses
OperatingExpenses
243815 USD
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-227742 USD
CY2021 us-gaap Profit Loss
ProfitLoss
-301261 USD
CY2020 us-gaap Profit Loss
ProfitLoss
-227742 USD
CY2021 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.01
CY2020 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
0
CY2021 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
37098910 shares
CY2020 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
37089102 shares
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
94800 USD
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-227742 USD
CY2020 us-gaap Stock Issued During Period Value Employee Benefit Plan
StockIssuedDuringPeriodValueEmployeeBenefitPlan
88000 USD
CY2020 crp Transfers Contributions From Parent
TransfersContributionsFromParent
95289 USD
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-315962 USD
CY2021 crp Transfers Contributions From Parent
TransfersContributionsFromParent
5648 USD
CY2021 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
0 USD
CY2021 us-gaap Stockholders Equity Note Spinoff Transaction
StockholdersEquityNoteSpinoffTransaction
-41294 USD
CY2021 crp Adjustments To Additional Paid In Capital Preferred Stock Split
AdjustmentsToAdditionalPaidInCapitalPreferredStockSplit
0 USD
CY2021 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
75000 USD
CY2021 us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
8747 USD
CY2021 crp Adjustments To Additional Paid In Capital Common Stock Split
AdjustmentsToAdditionalPaidInCapitalCommonStockSplit
0 USD
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-217514 USD
CY2021 us-gaap Profit Loss
ProfitLoss
-301261 USD
CY2020 us-gaap Profit Loss
ProfitLoss
-227742 USD
CY2021 us-gaap Share Based Compensation
ShareBasedCompensation
0 USD
CY2020 us-gaap Share Based Compensation
ShareBasedCompensation
88000 USD
CY2021 us-gaap Noncash Merger Related Costs
NoncashMergerRelatedCosts
22161 USD
CY2021 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
305 USD
CY2021 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-82 USD
CY2020 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-32918 USD
CY2021 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-18816 USD
CY2020 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-11535 USD
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-260507 USD
CY2020 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-95289 USD
CY2021 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 USD
CY2020 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 USD
CY2021 us-gaap Proceeds From Contributions From Parent
ProceedsFromContributionsFromParent
0 USD
CY2020 us-gaap Proceeds From Contributions From Parent
ProceedsFromContributionsFromParent
95289 USD
CY2021 us-gaap Proceeds From Repayments Of Notes Payable
ProceedsFromRepaymentsOfNotesPayable
195050 USD
CY2020 us-gaap Proceeds From Repayments Of Notes Payable
ProceedsFromRepaymentsOfNotesPayable
0 USD
CY2021 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
75000 USD
CY2020 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 USD
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
270050 USD
CY2020 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
95289 USD
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
9543 USD
CY2020 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
0 USD
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
0 USD
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
0 USD
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
9543 USD
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
0 USD
CY2021 us-gaap Interest Paid Net
InterestPaidNet
0 USD
CY2020 us-gaap Interest Paid Net
InterestPaidNet
0 USD
CY2021 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 USD
CY2020 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 USD
CY2021 us-gaap Use Of Estimates
UseOfEstimates
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The preparation of the financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Accordingly, actual results may differ from those estimates.</p>
CY2020Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
0 USD
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
0 USD
CY2021 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0 pure
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
37103394 shares
CY2021 crp Selling And Marketingpolicytextblock
SellingAndMarketingpolicytextblock
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Selling and Marketing costs are expensed as incurred. Such costs were $132,902 and $86,608 for the year ended December 31, 2021, and 2020, respectively, and are reported under selling, general and marketing in the accompanying statements of operations. </p>
CY2021 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
132902 USD
CY2020 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
86608 USD
CY2021 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1 integer
CY2021Q4 us-gaap Investments
Investments
0 USD
CY2020Q4 us-gaap Investments
Investments
50347 USD
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
5000000000 shares
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2021 us-gaap Common Stock Voting Rights
CommonStockVotingRights
The holders of common stock are entitled to one vote for each share held.
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
100000000 shares
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Preferred Stock Liquidation Preference
PreferredStockLiquidationPreference
1.00
CY2021 us-gaap Preferred Stock Voting Rights
PreferredStockVotingRights
Each share of Class A Preferred Stock entitles the holder thereof to 50 votes on any matters requiring a shareholder vote of the Company.
CY2021 us-gaap Preferred Stock Conversion Basis
PreferredStockConversionBasis
Each share of our Class A Preferred Stock is convertible into common stock on a one-for-25 basis at the option of the holder.
CY2021 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210 pure
CY2020 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210 pure
CY2021 us-gaap Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
-0.000 pure
CY2020 us-gaap Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
-0.000 pure
CY2021 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.210 pure
CY2020 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.210 pure
CY2020 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0 pure
CY2021Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
152265 USD
CY2020Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
89000 USD
CY2021Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
152265 USD
CY2020Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
89000 USD
CY2021Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
152265 USD
CY2020Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
89000 USD
CY2021Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0 USD
CY2020Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0 USD
CY2021Q2 us-gaap Salaries And Wages
SalariesAndWages
250000 USD
CY2021Q2 crp Term Of Agreement
TermOfAgreement
90 days

Files In Submission

Name View Source Status
0001477932-22-002081-index-headers.html Edgar Link pending
0001477932-22-002081-index.html Edgar Link pending
0001477932-22-002081.txt Edgar Link pending
0001477932-22-002081-xbrl.zip Edgar Link pending
crp-20211231.xsd Edgar Link pending
crp-20211231_cal.xml Edgar Link unprocessable
crp-20211231_def.xml Edgar Link unprocessable
crp-20211231_lab.xml Edgar Link unprocessable
crp-20211231_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
onesix_10k.htm Edgar Link pending
onesix_10kimg1.jpg Edgar Link pending
onesix_10kimg2.jpg Edgar Link pending
onesix_10k_htm.xml Edgar Link completed
onesix_ex311.htm Edgar Link pending
onesix_ex312.htm Edgar Link pending
onesix_ex321.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending